About US
Contact us
-
FDA approves use of Merck’s HPV vaccine for up to age 45The US Food and Drug Administration (FDA) has approved the use of Merck’s Gardasil 9 HPV vaccine in adults aged from 27 to 45 years. Gardasil 9 is indicated for the prevention of certain cancers and2018/10/9
-
NHS England reaches deal with Gilead on CAR-T therapy YescartaNational Health Service (NHS) England has reached an agreement with Gilead Sciences to provide the pharmaceutical company’s chimeric antigen receptor T-cell (CAR-T) therapy Yescarta (axicabtagene cilo2018/10/9
-
Janssen signs $3.7bn licence agreements with ArrowheadJanssen Pharmaceuticals has signed a $3.7bn licence and collaboration agreement with Arrowhead Pharmaceuticals for the development and commercialisation of a new therapy candidate, ARO-HBV. ARO-HBV i2018/10/8
-
Vertex’s cystic fibrosis drugs become publicly available in DenmarkVertex Pharmaceuticals has signed an access agreement with Denmark’s pharmaceutical procurement agency Amgros for public hospital use of all current and future drugs for mutations in the cystic fibros2018/10/8
-
EMA, MHRA and GlaxoSmithKline blast BMJ’s ‘flawed’ pandemic flu vaccine safety reportEuropean drug regulatory bodies and GlaxoSmithKline have quickly rallied their rebuttals to a BMJ report that questioned the safety profile of GSK’s now-unavailable pandemic flu vaccine Pandemrix, as2018/9/30
-
Pfizer's once-failed Vizimpro rebounds with targeted lung cancer approvalIt’s been a long road for Pfizer’s dacomitinib, but the targeted lung cancer drug final has an FDA green light. Late Thursday, the agencyhandedPfizer an OK for the cancer-fighter, which will bear the2018/9/30
-
Novartis signs Chinese manufacturing deal with Cellular Biomedicines for KymriahSwiss pharmaceutical company Novartis has signed an exclusive marketing agreement with Cellular Biomedicines to manufacture its CAR-T therapy Kymriah in China. The agreement is part of Novartis’ effo2018/9/29
-
US and Cuba form biotech joint venture to develop cancer drugsUS and Cuba have formed a biotech joint venture, called Innovative Immunotherapy Alliance, focused on the research and development of cancer drugs to prolong and improve survival of patients2018/9/29
-
Big Pharma's antibody drugs for asthma show benefits but cost 50% too much: ICERNew antibody-based treatments are better than traditional drugs for moderate to severe asthma, but they still cost too much, a U.S. drug cost watchdog says. More than 50% too much, in fact. In a newd2018/9/28
-
How Samsung BioLogics’ end-to-end service maximizes client satisfactionSamsung BioLogics has come a long way in seven years. Having started out as a CMO, the company has grown into an end-to-end service provider with capabilities spanning far beyond manufacturing, enabli2018/9/28